Treatment option for depression offered in the United States.
D018687:Antidepressive Agents, Second-Generation / Q000600:supply & distribution / Q000627:therapeutic use*; D003511:Cyclohexanols / Q000600:supply & distribution / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000188:drug therapy*; D017277:Drug Approval; D006801:Humans; D014481:United States; D000069470:Venlafaxine Hydrochloride
D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D000069470:Venlafaxine Hydrochloride